Pharmosa Biopharm Inc. (TPEX: 6875)
Taiwan
· Delayed Price · Currency is TWD 64.80
+0.20 (0.31%)
Oct 11, 2024, 1:30 PM CST
Pharmosa Biopharm Company Description
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan.
It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease.
The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016.
Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.
Pharmosa Biopharm Inc.
| Country | Taiwan |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Pei Ken |
Contact Details
Address: No. 66, Sanchong Road Taipei City, 11502 Taiwan | |
| Phone | 886 2 2782 7561 |
| Website | pharmosa.com.tw |
Stock Details
| Ticker Symbol | 6875 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006875008 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Pei Ken Ph.D. | President, GM and Director |
| Winny Yang | Vice President of Finance and Accounting |
| Hui-An Pao | Vice President of Operations |
| Ru-Yun Lin M.B.A. | Vice President of Administration |